Why is Ipca Labs falling/rising?

As of 31-Jul, Ipca Laboratories Ltd is experiencing a decline in its stock price, currently at Rs 1,481.40, which reflects a decrease of Rs 47.6 or 3.11%. Today's price summary indicates that the stock underperformed its sector by 1.62%, with an intraday low of Rs 1,460.75, marking a drop of 4.46%. Despite this decline, the stock has shown positive performance over the past month, gaining 7.50%, and has outperformed the broader market over the last year with a return of 13.31%. The company maintains a low debt-to-equity ratio of 0.03, has reported positive results for the last four consecutive quarters, and boasts high institutional holdings at 46.87%, which suggests confidence from more knowledgeable investors.
In the broader market context, the stock's recent performance contrasts with the benchmark Sensex, which has seen a decline of 1.22% over the past week. While Ipca Laboratories has underperformed in the short term, it has demonstrated resilience with a significant return over the past year compared to the negative returns of the broader market. The stock's liquidity remains adequate for trading, and rising investor participation, as indicated by a 29.57% increase in delivery volume, may provide some support despite the current price drop.